证券代码：603086 证券简称：先达股份 公告编号：2024-023 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 17 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 151,284,573 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 34.7930 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 山东先达农化股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 本次股东大会由公司董事会召集，董事长王现全先生主持，会议采取现场投 票与网络投票相结合的方式进行表决，会议的召集和召开程序、表决方式均符合 《公司法》及《公司章程》的有关规定。 (五) 公司董事、监事和董事会秘书的出席情况 1、公司在任董事 7 人，出席 7 人； (一) 股东大会召开的时间：2024 年 5 月 22 日 (二) 股东大会 ...

山东先达农化股份有限公司 关于 2023 年度业绩暨现金分红说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 山东先达农化股份有限公司（以下简称"公司"）于 2024 年 5 月 16 日（星 期 四 ） 10:00-11:00 在 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/），以网络文字互动方式召开公司 2023 年度业 绩暨现金分红说明会。关于本次业绩说明会的召开事项，公司已于 2024 年 5 月 10 日在《中国证券报》《上海证券报》《证券时报》《证券日报》及上海证券 交易所网站上披露了《关于召开 2023 年度业绩暨现金分红说明会的公告》（公 告编号：2024-021）。现将有关事项公告如下： 一、本次说明会召开情况 2024 年 5 月 16 日，公司董事长王现全先生、独立董事袁成雷先生、董事兼 总经理门亮先生、董事会秘书兼财务总监江广同先生出席了本次说明会，并对投 资者提出的问题进行了回答。 二、投资者提出 ...

证券代码：603086 证券简称：先达股份 公告编号：2024-021 山东先达农化股份有限公司 关于召开2023年度业绩暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、说明会类型 山东先达农化股份有限公司（以下简称"公司"）已于 2024 年 04 月 30 日在 上海证券交易所网站（www.sse.com.cn）及指定信息披露媒体披露了公司 2023 年年度报告。为便于广大投资者更全面深入地了解公司 2023 年度经营成果及财 务状况，公司计划于 2024 年 05 月 16 日上午 10:00-11:00 通过网络互动形式召 开 2023 年度业绩暨现金分红说明会，就投资者普遍关注的问题进行沟通与交流， 广泛听取投资者的意见和建议。 二、说明会召开的时间、地点 （一）召开时间：2024 年 05 月 16 日(星期四)上午 10:00-11:00 （二）召开地点：上证路演中心（http://roadshow.sseinfo.com/） 1 公司董事长王现全先生、独立董事袁 ...

Financial Performance - In 2023, XianDa Co. reported its first annual loss since establishment, with a significant decline in the pesticide industry, where profits dropped by 60% year-on-year[4]. - The company's operating revenue for 2023 was approximately ¥2.48 billion, a decrease of 20.58% compared to ¥3.13 billion in 2022[32]. - The net profit attributable to shareholders was approximately -¥97.89 million, representing a decline of 125.68% from ¥381.20 million in the previous year[32]. - The net cash flow from operating activities was -¥890,425.90, a significant drop of 100.24% compared to ¥364.45 million in 2022[32]. - The revenue after excluding non-main business income was approximately ¥2.46 billion, down 20.77% from ¥3.10 billion in 2022[32]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately -¥109.87 million, a decrease of 126.14% from ¥420.22 million in 2022[32]. - The company's net assets attributable to shareholders decreased by 7.93% to CNY 2,003,780,750.03 compared to the end of 2022[33]. - Total assets decreased by 1.06% to CNY 3,317,294,993.02 compared to the end of 2022[33]. - Basic earnings per share dropped to -CNY 0.23, a decline of 126.14% compared to the previous year[33]. - The weighted average return on net assets fell by 23.18 percentage points to -4.55%[33]. Market Strategy and Product Development - The company plans to focus on core product production capabilities and has suspended investments in homogeneous products, such as the 5,000 tons/year Acetochlor project[6]. - XianDa Co. aims to enhance its market presence by developing unique, differentiated herbicides suitable for the Chinese market, leveraging its proprietary technology and partnerships with top research institutions[9]. - The company has established a new drug research base in Shenyang and has successfully launched its first proprietary herbicide, Quinclorac, in 2021, which is the world's first selective herbicide for sorghum fields[10]. - The company plans to continue focusing on high-end herbicide technology innovation and product development amid market challenges[39]. - The company is focusing on developing proprietary products to address the emergence of resistant weeds, adapting to changes in weed communities due to large-scale herbicide use[116]. - The company will expand the registration scope of proprietary products like "Quinclorac" and "2,4-D Butyric Acid" to maximize market potential in 2024[118]. - The company plans to invest in a new automated comprehensive formulation project with an annual capacity of 20,000 tons, aimed at enhancing processing capabilities for various formulation types[45]. Research and Development - The company has successfully developed patented compounds such as Quizalofop and Pyrazolyl, with Quizalofop already launched in the domestic market and registered in Pakistan[41]. - The company has established a formulation development center to optimize formulation research and development processes, aiming to enhance R&D efficiency and expand the product line[42]. - The company is focusing on research and development of new herbicide compounds in collaboration with research institutions and universities[121]. - The company has established a modern laboratory of 5,000 square meters in Shenyang, enhancing its R&D capabilities through project management and collaboration with universities[91]. - The company has implemented a performance evaluation mechanism for senior management to align compensation with long-term business interests[166]. Environmental and Safety Management - The company has implemented a comprehensive safety management strategy, enhancing safety production levels and ensuring normal operations[46]. - The company has committed to fulfilling its environmental responsibilities by reducing traditional energy use and enhancing resource conservation[190]. - The company has established an environmental self-monitoring plan in accordance with the "Technical Specifications for the Application and Issuance of Pollutant Discharge Permits - Pesticide Manufacturing Industry" (HJ862-2017), detailing monitoring indicators, points, frequency, methods, and standards for pollutant emissions[188]. - The company has conducted emergency drills in accordance with the emergency response plan requirements during the reporting period[187]. - The company has implemented carbon reduction measures, including energy management, replacing high-energy-consuming equipment, and improving waste gas treatment efficiency, contributing to reduced carbon emissions[190]. Governance and Compliance - The company has established a sound internal governance structure, ensuring compliance with laws and regulations during shareholder meetings and board operations[131]. - The company guarantees that all shareholders, especially minority shareholders, can fully exercise their legal rights during shareholder meetings[131]. - The company maintains strict information disclosure practices, ensuring that all shareholders receive fair and timely information[132]. - The company has not faced any penalties from securities regulatory agencies in the past three years[143]. - The company has a structured approach to governance, ensuring that directors abstain from discussions regarding their own remuneration[141]. Shareholder Returns and Capital Management - The company plans to distribute cash dividends amounting to at least 10% of the net profit attributable to shareholders for the year, with a cumulative distribution of no less than 30% of the average distributable profit over any three consecutive years[158]. - The company approved a plan for shareholder returns for the next three years (2023-2025) during the annual general meeting[133]. - The total cash dividend amount (including tax) is ¥77.65 million, which also accounts for 20.37% of the net profit attributable to ordinary shareholders[161]. - The company plans to issue 4 bonus shares for every 10 shares held and distribute a cash dividend of ¥2.50 per 10 shares (including tax)[160]. Operational Challenges and Market Outlook - Despite current industry challenges, the overall market for herbicides remains optimistic, with expected stabilization and potential rebound in product prices[12]. - The domestic pesticide industry is facing short-term pressure due to supply-demand imbalances, with profits in the sector declining by 60% year-on-year in 2023[48]. - The global agricultural pesticide market reached a total of 3.54 million tons in 2021, with major usage concentrated in countries like the USA, Brazil, and China[83]. - The global agricultural chemical market is projected to reach $82.845 billion in 2023, with a slight year-on-year increase of 0.1%[48]. Employee Management and Development - The company has a structured compensation system that includes guaranteed, allowance-based, and incentive-based salaries, aiming to motivate employees and align their goals with the company's objectives[153]. - The company has implemented a training program that combines online and offline methods to meet both corporate and employee development needs[155]. - The total number of employees in the parent company is 384, while the main subsidiaries employ 1,796, resulting in a total of 2,180 employees[152].

Financial Performance - The company's operating revenue for Q1 2024 was ¥489,964,898.81, representing a decrease of 10.56% compared to the same period last year[4]. - The net profit attributable to shareholders was a loss of ¥13,762,047.97, a decline of 130.98% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥16,014,119.47, down 144.65% from the previous year[4]. - Basic and diluted earnings per share were both -¥0.03, reflecting a decrease of 130.00% due to the decline in net profit[4]. - Net profit for Q1 2024 was a loss of ¥13,769,723.01, compared to a profit of ¥45,223,909.14 in Q1 2023, indicating a significant decline[18]. - The total comprehensive income attributable to the parent company for Q1 2024 was -¥13,762,047.97, a decrease from ¥44,424,279.36 in Q1 2023[22]. - The company's basic and diluted earnings per share for Q1 2024 were both -¥0.03, compared to ¥0.10 in Q1 2023, reflecting a decline in profitability[22]. Revenue and Costs - Total operating revenue for Q1 2024 was ¥489,964,898.81, a decrease of 10.5% compared to ¥547,800,695.47 in Q1 2023[17]. - Total operating costs for Q1 2024 were ¥501,696,305.69, slightly down from ¥505,720,886.53 in Q1 2023[17]. - Total revenue from sales of goods and services in Q1 2024 was ¥544,356,184.54, down 15.1% from ¥641,006,858.07 in Q1 2023[22]. - The decline in net profit was mainly attributed to a decrease in the sales prices of the company's main products[7]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,463,452,806.93, an increase of 4.41% from the end of the previous year[4]. - The company's total assets increased to ¥3,463,452,806.93 in Q1 2024 from ¥3,317,294,993.02 in Q1 2023, reflecting a growth of 4.4%[14]. - Total liabilities rose to ¥1,463,574,586.16 in Q1 2024, up from ¥1,306,139,641.33 in Q1 2023, an increase of 12.0%[13]. - The equity attributable to shareholders decreased by 0.56% to ¥1,992,511,294.15 compared to the end of the previous year[4]. - The company’s total equity decreased to ¥1,999,878,220.77 in Q1 2024 from ¥2,011,155,351.69 in Q1 2023, a decline of 0.6%[14]. Cash Flow - The net cash flow from operating activities increased by 277.74% to ¥72,516,450.20, primarily due to the use of bank acceptance bills for procurement settlements[7]. - In Q1 2024, the company reported a net cash flow from operating activities of ¥72,516,450.20, a significant improvement compared to a net outflow of -¥40,800,207.31 in Q1 2023[22]. - The company incurred financial expenses of ¥282,759.06 in Q1 2024, significantly lower than ¥7,649,800.71 in Q1 2023, indicating improved financial management[18]. - The company experienced a net cash outflow from investing activities of -¥230,011,834.59 in Q1 2024, compared to -¥186,084,397.20 in Q1 2023, indicating increased investment expenditures[23]. - Cash outflows from financing activities in Q1 2024 amounted to ¥103,466,142.21, compared to only ¥1,119,016.67 in Q1 2023, indicating a significant increase in financing costs[24]. - The net increase in cash and cash equivalents for Q1 2024 was -¥156,476,881.96, compared to -¥143,054,285.17 in Q1 2023, showing a worsening cash position[24]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,681[9]. Non-Recurring Gains - The company reported non-recurring gains of ¥2,252,071.50, primarily from government subsidies and other non-operating income[6].

证券代码：603086 证券简称：先达股份 公告编号：2024-020 山东先达农化股份有限公司 2024 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司行业信息披露指引第十八号—化工》等相关 规定，山东先达农化股份有限公司（以下简称"公司"）现将 2024 年第一季度 主要经营数据披露如下（均不含税）： | 产品 | 主要产品 | 2024 | 年 1-3 | 月产 | 2024 年 | 1-3 | 月销 | 2024 | 年 | 1-3 | 月销 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 类别 | | | 量（吨） | | 量（吨） | | | 售金额（万元） | | | | | 除草剂 | 烯草酮系列 | | 1,761.05 | | 1,760.84 | | | 12,986.42 | | | | | | 咪草烟系列 | | 279.20 | ...

证券代码：603086 证券简称：先达股份 公告编号：2024-019 山东先达农化股份有限公司 2023 年度主要经营数据公告 三、主要原材料的价格变动情况 | 主要原材料 | 2022 年平均进价 | 2023 年平均进价 | 变动比率（%） | | --- | --- | --- | --- | | | （万元/吨） | （万元/吨） | | | 氯代特戊酰氯 | 3.01 | 2. 08 | -30. 90 | | --- | --- | --- | --- | | 巴豆醛 | 1.54 | 1. 30 | -15. 58 | | 氯代胺 | 6. 37 | 3. 94 | -38. 15 | | 2,3-吡啶二甲酸 | 8.78 | 9. 83 | 11.96 | | 邻氯氯芋 | 2. 15 | 1.08 | -49.77 | | 吗林 | 1.51 | 1. 30 | -13.91 | 特此公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司行业信息披露指引第十八号—化工》等 ...

Financial Performance - Total operating revenue for 2023 was CNY 248,248.51 million, a decrease of 20.58% compared to the previous year[4] - Net profit attributable to shareholders was CNY -9,828.19 million, a decline of 125.78% year-on-year[4] - Operating profit decreased by 129.79% year-on-year, with total profit down by 130.47%[7] - Basic earnings per share were CNY -0.23, a decrease of 126.14% compared to the previous year[4] - The weighted average return on net assets was -4.57%, a decrease of 23.20 percentage points year-on-year[4] Assets and Equity - Total assets at the end of the reporting period were CNY 328,295.11 million, a decrease of 2.08% from the beginning of the period[6] - Shareholders' equity attributable to the company was CNY 200,338.56 million, down 7.95% from the beginning of the period[6] Market Conditions - The company faced significant pressure from high overseas inventory and domestic capacity release, leading to a decline in pesticide prices[6] - The company reported a significant drop in sales prices for major products, resulting in losses for some products[6] Financial Reporting - The financial data presented is preliminary and unaudited, with potential discrepancies in the final annual report[8]

证券代码：603086 证券简称：先达股份 公告编号：2024-004 山东先达农化股份有限公司 一、签字注册会计师及项目质量控制复核人变更的情况 大华会计师事务所（特殊普通合伙）作为公司 2023 年度财务报表和内部控 制的审计机构，原委派邱俊洲和覃业贵为签字注册会计师、陈葆华为项目质量控 制复核人，为公司提供审计服务。鉴于原签字注册会计师覃业贵、原项目质量控 制复核人员陈葆华已离职，现委派王艳丽接替覃业贵作为签字注册会计师，黄海 波接替陈葆华作为项目质量控制复核人。变更后，公司 2023 年度财务报表和内 部控制审计签字注册会计师为邱俊洲和王艳丽，项目质量控制复核人为黄海波。 二、本次变更注册会计师及项目质量控制复核人的信息 （一）变更注册会计师的信息 关于变更签字注册会计师及项目质量控制复核人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 山东先达农化股份有限公司（以下简称"公司"）于 2023 年 4 月 25 日召开 第四届董事会第十一次会议，审议通过了《关于续聘公司 2023 年度审计机构的 议案》， ...

证券代码：603086 证券简称：先达股份 公告编号：2024-003 山东先达农化股份有限公司 关于全资子公司完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 山东先达农化股份有限公司（以下简称"公司"）全资子公司潍坊先达化工 有限公司对法人代表进行变更，相关工商变更登记事项已于近日完成，并取得了 潍坊滨海经济技术开发区行政审批服务局颁发的《营业执照》，变更后的相关信 息如下： 名称：潍坊先达化工有限公司 类型：有限责任公司（自然人投资或控股的法人独资） 住所：潍坊滨海经济开发区临港化工园东二户 法定代表人：张建国 成立日期：2006 年 06 月 05 日 注册资本：人民币壹亿伍仟万元整 经营范围：农药原药、制剂、农药化工中间体的研发、生产（合成、配制） 和销售（以安全生产许可证核准的产品为准，有效期限以许可证为准）；生产、 销售：亚磷酸、醇基液体燃料（有限期限以许可证为准）；生产、销售：氯化钠、 醋酸钠；经营本企业自产产品及技术的出口业务和企业所需的机械设备、零配件、 原辅材料及技术的进出口业 ...